NutraLife BioSciences, Inc. (NLBS)
NutraLife BioSciences, Inc. operates in the Drug Manufacturers - Specialty & Generic industry of the Healthcare sector, headquartered in Coconut Creek, FL, US. The stock last traded at $0.00, giving a market capitalisation of $17,662. On trailing twelve-month figures it carries a trailing P/E of -0.00, a net margin of -930.0%. Its beta of -15.21 implies it has historically moved less than the broad market.
NutraLife BioSciences, Inc., operating with its subsidiaries, specializes in the creation, production, and distribution of a diverse range of health-oriented products. This includes nutraceuticals, dietary supplements, general wellness items, and a significant line of cannabidiol (CBD) products. The company's CBD portfolio is comprehensive, featuring cannabinoid-rich hemp oil sourced from industrial hemp, tinctures, and a variety of topical solutions like lotions and oils designed for direct skin application to alleviate pain or inflammation. Their CBD offerings also extend to face creams, massage oils, nutraceutical sprays enhanced with CBD, and specialized products for pets. In addition to its CBD range, NutraLife BioSciences also manufactures skincare items and hand sanitizers. Customers can acquire the company's products directly from its website, nutralifebiosciences.com, or through a network of private label distributors, other online retailers, and traditional brick-and-mortar stores. Established in 2010 and based in Coconut Creek, Florida, the enterprise was previously known as NutraFuels, Inc. It officially adopted its current name, NutraLife BioSciences, Inc., in March 2019.
NutraLife BioSciences, Inc. is most often compared with the following Healthcare names: